Publikationen in Zusammenarbeit mit Forschern von Imperial College London (2)

2019

  1. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: Conceptual framework and therapeutic potential

    Cardiovascular Diabetology, Vol. 18, Núm. 1

2017

  1. Evolocumab and clinical outcomes in patients with cardiovascular disease

    New England Journal of Medicine, Vol. 376, Núm. 18, pp. 1713-1722